Nuance Medical Acquires BIOCORNEUM Brand from Sientra

BioStem Technologies Acquires BioTissue's Surgical and Wound Care Business

January 22, 2026

Medical Devices

BioStem Technologies (OTC: BSEM) has acquired the surgical and wound care business of BioTissue Holdings, Inc. for approximately $15 million upfront, with up to $25 million of contingent milestone and royalty payments. The deal includes the Neox and Clarix product lines, a nationwide commercial sales organization and assigned GPO contracts, expanding BioStem's access into hospital inpatient and outpatient wound-care markets and adding assets that generated roughly $29 million in 2025.

DermBiont Acquires SeylanMED to Expand Dermatology Pipeline

October 21, 2020

Biotechnology

DermBiont, a Boston-based clinical-stage precision dermatology company, has acquired SeylanMED, adding a targeted topical AKT inhibitor gel candidate for seborrheic keratosis to its pipeline. The acquisition expands DermBiont's therapeutic modalities and accelerates its objective to develop targeted topical treatments and live bacterial therapeutics for skin diseases.

Clinical Skin Acquires Glytone from Pierre Fabre Laboratories

March 4, 2024

Consumer Products

Clinical Skin has acquired cosmeceutical skincare brand Glytone from Pierre Fabre Laboratories in a strategic move to expand its science-backed product portfolio. Glytone, known for dermatologist-trusted formulations targeting aging, hyperpigmentation and acne, will be integrated into Clinical Skin's offering to further scale its presence in the skincare market.

BioDerm (Mountaingate) Acquires Argentum Medical

February 1, 2023

Medical Devices

BioDerm, a portfolio company of Mountaingate Capital, has acquired Argentum Medical and combined the business with BioDerm to create a larger wound-care and infection-prevention platform. Mountaingate supported the combination through its existing ownership of BioDerm and new investment in the combined entity, with Five Points Capital providing unitranche financing to support the refinancing and acquisition; Shore Capital Partners sold Argentum.

Bioventus Acquires Bioness, Inc.

March 30, 2021

Medical Devices

Bioventus Inc. acquired Bioness, Inc. for $45 million in up-front consideration plus up to $65 million of contingent consideration, making Bioness a wholly‑owned subsidiary. The acquisition expands Bioventus' rehabilitation and neuromodulation product portfolio and R&D pipeline, and is expected to be accretive to revenue by leveraging Bioventus' global commercial infrastructure.

NovaBay Pharmaceuticals Acquires DERMAdoctor

September 28, 2021

Consumer Products

NovaBay Pharmaceuticals, Inc. has entered into a definitive agreement to acquire DERMAdoctor, LLC for $15.0 million ( $12.0 million cash at closing plus up to $3.0 million in earnouts). The deal brings DERMAdoctor's ~30-product skincare portfolio and its 13-person team (co-founders Audrey and Jeff Kunin to remain) into NovaBay's commercial platform to expand its presence in the U.S. beauty market and capture revenue and operating synergies.